Browse treatments

…ll recruitment, and activation mechanisms. Clinically promising cancer immunotherapies harnessing cytokines and chemokines are expanding,2 yet the spa…

…Background Although T cell-targeted immunotherapies have achieved significant clinical success, a considerable prop…

…Background Cancer immunotherapies have significantly improved treatment efficacy and patient surv…

…e are highly valuable models for the preclinical development of cancer immunotherapies. However, conventional models often fail to mount robust and tr…

… core needle biopsies from patients with solid tumors receiving immune checkpoint blockade. The safety of repeat CD8 PET was additionally analyzed.Results…

…Background Cancer immunotherapies have become an effective tool by manipulating cellular immune r…

…t (TME) plays a crucial role in determining patient response to cancer immunotherapies. Cellular therapies, immune checkpoint inhibitors, and other mo…

…Background Cancer immunotherapies, although they can confer potent and durable antitumor effects,…

…s improves outcomes in patients with neurological toxicity from cancer immunotherapies.…

…Despite advances in cancer immunotherapies across various cancers, survival outcomes in colorectal cancer …